What does Antleron do?
Antleron specializes in developing advanced biomanufacturing solutions for the production of cell and gene therapies. The company focuses on providing innovative technologies and services that enhance the efficiency and scalability of bioprocesses. By integrating cutting-edge automation and digitalization, Antleron aims to accelerate the development of life-saving treatments.
- Sectors
- Event agencies
- Signals
-
ProfitableProfitable € 276K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.60MStrong equity provides a buffer against setbacks.
Low riskLow risk 70.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.38A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 528KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 482KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 11.1%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
1.61M
|
€
975K
|
€
1.41M
|
€
1.06M
|
|
|
€
482K
|
€
-118K
|
€
521K
|
€
317K
|
|
|
€
276K
|
€
-298K
|
€
334K
|
€
292K
|
|
|
€
1.60M
|
€
1.38M
|
€
1.73M
|
€
1.38M
|
|
|
70.06%
|
59.31%
|
82.14%
|
74.04%
|
|
|
€
685K
|
€
950K
|
€
376K
|
€
485K
|
|
|
€
263K
|
€
1.13M
|
€
979K
|
€
1.14M
|
|
|
14.50
|
15.10
|
13.50
|
12.20
|
Publications 7
All publications- Maatschappelijke Zetel 02/07/2026
- Ontslagen - Benoemingen 13/08/2025
- Ontslagen - Benoemingen 12/08/2022
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 07/12/2018
- Kapitaal - Aandelen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 17/01/2018
Frequently asked questions
Answers to the most common questions about Antleron, based on official government data and the filed annual accounts.
What is the VAT number of Antleron?
The VAT number of Antleron is BE0505.975.160.
How many employees work at Antleron?
In 2025, Antleron employed 14.50 full-time equivalents (FTE).
When was Antleron established?
Antleron was founded in 21-11-2014.
What is the official address of Antleron?
The official address of Antleron is Ambachtenlaan 1 Leuven 3001.
What is the legal form of Antleron?
The juridical form of Antleron is Public limited company (NV/SA).
What is the annual revenue of Antleron?
The 2025 accounts of Antleron do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Antleron do?
Antleron specializes in developing advanced biomanufacturing solutions for the production of cell and gene therapies. The company focuses on providing innovative technologies and services that enhance the efficiency and scalability of bioprocesses. By integrating cutting-edge automation and digitalization, Antleron aims to accelerate the development of life-saving treatments.
Is Antleron a reliable company?
Antleron is a registered Rechtspersoon with company number 0505.975.160 and can be verified through the official CBE database.
What is the credit limit of Antleron?
The estimated credit limit of Antleron is €598,470.
Is Antleron still active?
Antleron currently has the status "Normal situation" and is active.